One in five patients on Nirmatrelvir–Ritonavir experience virologic rebound, new observational study reveals Post author: Post published:November 16, 2023 Post category:uncategorized The frequency of viral rebound (VR) among acute coronavirus disease 2019 patients. You Might Also Like New findings on calcium transport in Listeria bacteria may enhance food safety October 14, 2024 Brain-computer interface translates ALS patient’s brain activity into spoken words May 8, 2024 Diet and gut microbiota: how what you eat shapes your gut health May 13, 2024